{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:13:12Z","timestamp":1787008392206,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":1590,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"PNP Therapeutics, Inc","award":["NIH T32CA091078"],"award-info":[{"award-number":["NIH T32CA091078"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1093\/annonc\/mdv196","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T20:00:36Z","timestamp":1429646436000},"page":"1481-1487","source":"Crossref","is-referenced-by-count":37,"title":["Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors"],"prefix":"10.1016","volume":"26","author":[{"given":"E.L.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.B.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.W.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Richman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Conry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.R.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nabell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Sorscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv196_bb0010","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0006-2952(98)00034-3","article-title":"Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells","volume":"55","author":"Parker","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1093\/annonc\/mdv196_bb0015","first-page":"3339","article-title":"Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene","volume":"55","author":"Hughes","year":"1995","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdv196_bb0020","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1074\/jbc.273.4.2322","article-title":"Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase","volume":"273","author":"Hughes","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdv196_bb0025","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1158\/0008-5472.CAN-04-0012","article-title":"Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene","volume":"64","author":"Hong","year":"2004","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdv196_bb0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/cgt.2011.4","article-title":"Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase","volume":"18","author":"Parker","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"10.1093\/annonc\/mdv196_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.cgt.7701013","article-title":"Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts","volume":"14","author":"Kikuchi","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"10.1093\/annonc\/mdv196_bb0040","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1158\/0008-5472.CAN-07-1252","article-title":"Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine","volume":"67","author":"Ungerechts","year":"2007","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdv196_bb0045","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1097\/00006676-200403000-00020","article-title":"Suicide gene\/prodrug therapy for pancreatic adenocarcinoma by E. coli purine nucleoside phosphorylase and 6-methylpurine 2\u2032-deoxyriboside","volume":"28","author":"Deharvengt","year":"2004","journal-title":"Pancreas"},{"key":"10.1093\/annonc\/mdv196_bb0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/jhep.2001.26749","article-title":"Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro","volume":"34","author":"Krohne","year":"2001","journal-title":"Hepatology"},{"key":"10.1093\/annonc\/mdv196_bb0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.510310310","article-title":"Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene","volume":"31","author":"Mohr","year":"2000","journal-title":"Hepatology"},{"key":"10.1093\/annonc\/mdv196_bb0060","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/sj.mt.6300291","article-title":"An immunocompetent murine model for oncolysis with an armed and targeted measles virus","volume":"15","author":"Ungerechts","year":"2007","journal-title":"Mol Ther"},{"key":"10.1093\/annonc\/mdv196_bb0065","unstructured":"National Cancer Institute NCI Guidelines for Investigators. Adverse Event Reporting Requirements for DCTD (CTEP and CIP) and DCP INDs and IDEs. http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/aeguidelines.pdf (3 March 2015, date last accessed)."},{"key":"10.1093\/annonc\/mdv196_bb0070","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/sj.gt.3301286","article-title":"In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells","volume":"7","author":"Gadi","year":"2000","journal-title":"Gene Ther"},{"key":"10.1093\/annonc\/mdv196_bb0075","unstructured":"R Core Team. R: A language and environment for statistical computing. http:\/\/www.R-project.org (20 January 2015, date last accessed)."},{"key":"10.1093\/annonc\/mdv196_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00280-012-1908-9","article-title":"In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase","volume":"70","author":"Sorscher","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdv196_bb0085","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/sj.gt.3300561","article-title":"Foamy virus vectors for suicide gene therapy","volume":"4","author":"Nestler","year":"1997","journal-title":"Gene Ther"},{"key":"10.1093\/annonc\/mdv196_bb0090","first-page":"2075","article-title":"Relative efficiency of tumor cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors","volume":"3","author":"Lockett","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdv196_bb0095","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jgm.1620","article-title":"Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara(R) for prostate cancer therapy","volume":"13","author":"Xie","year":"2011","journal-title":"J Gene Med"},{"key":"10.1093\/annonc\/mdv196_bb0100","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1089\/hum.1998.9.11-1617","article-title":"In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors","volume":"9","author":"Martiniello-Wilks","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1093\/annonc\/mdv196_bb0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/10430349950018724","article-title":"Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy","volume":"10","author":"Puhlmann","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1093\/annonc\/mdv196_bb0110","doi-asserted-by":"crossref","first-page":"32552","DOI":"10.1074\/jbc.M111.236117","article-title":"Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1)","volume":"286","author":"Yao","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdv196_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9044-4","article-title":"The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs","volume":"26","author":"Zhang","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1093\/annonc\/mdv196_bb0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.cgt.7700799","article-title":"Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses","volume":"12","author":"Currier","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"10.1093\/annonc\/mdv196_bb0125","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/gt.2008.2","article-title":"Factors influencing retention of adenovirus within tumours following direct intratumoural injection","volume":"15","author":"Bazan-Peregrino","year":"2008","journal-title":"Gene Ther"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419345120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419345120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/7\/1481\/5201831\/mdv196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T03:54:14Z","timestamp":1624506854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419345120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0923753419345120"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv196","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}